(Q37697808)

22 August 2017

1 reference

title

Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation (English)

1 reference

22 August 2017

0 references

Georgia Sotiropoulou

1

1 reference

22 August 2017

Georgios Pampalakis

series ordinal

2

1 reference

22 August 2017

publication date

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

391

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

321-331

1 reference

Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

IL-1, IL-18, and IL-33 families of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Allergy to human seminal fluid: cross-reactivity with dog dander

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Enzymatic properties of rat myelencephalon-specific protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

The autolytic regulation of human kallikrein-related peptidase 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Interleukin 20: discovery, receptor identification, and role in epidermal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Involvement of semenogelin-derived peptides in the antibacterial activity of human seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

A proteolytic cascade of kallikreins in the stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Tumors sound the alarmin(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Defensins: antimicrobial peptides of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Human kallikrein 13 involvement in extracellular matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Identification of immunoreactive tissue prokallikrein on the surface membrane of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Plasminogen activator/plasmin system: a major player in wound healing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Transcriptional profiling of keratinocytes reveals a vitamin D-regulated epidermal differentiation network

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Kallikrein-related peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Proteinase-activated receptors, targets for kallikrein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Cloning and characterization of novel isoforms of the human kallikrein 6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

The epigenetic basis for the aberrant expression of kallikreins in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Human caspases: activation, specificity, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Expression of kallikrein 7 diminishes pancreatic cancer cell adhesion to vitronectin and enhances urokinase-type plasminogen activator receptor shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

The extracellular matrix protein fibronectin is a substrate for kallikrein 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Potential scope of action of tissue kallikreins in CNS immune-mediated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Influence of pH on wound-healing: a new perspective for wound-therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Distribution of 15 human kallikreins in tissues and biological fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Role of tissue kallikrein-related peptidases in cervical mucus remodeling and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Functional roles of human kallikrein-related peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Autoimmunity against a tissue kallikrein in IQI/Jic Mice: a model for Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Immunotherapy with dendritic cells for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

CMAP27, a novel chicken cathelicidin-like antimicrobial protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Human prostate-specific antigen: structural and functional similarity with serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

IgE-mediated allergy against human seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Tissue kallikrein mK13 is a candidate processing enzyme for the precursor of interleukin-1beta in the submandibular gland of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Activation profiles and regulatory cascades of the human kallikrein-related peptidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Antimicrobial and Protease Inhibitory Functions of the Human Cathelicidin (hCAP18/LL-37) Prosequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Cathelicidins, multifunctional peptides of the innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Identification and characterization of novel reptile cathelicidins from elapid snakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Activity of a newly identified serine protease in CNS demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Activation of the 92 kDa type IV collagenase by tissue kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Regulation of 92-kDa Gelatinase B Activity in the Extracellular Matrix by Tissue Kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.036

21 January 2018

Identifiers

DOI

10.1515/BC.2010.036

1 reference

22 August 2017

1 reference